Literature DB >> 8591990

Evidence suggesting a stimulatory role for interleukin-10 in erythropoiesis in vitro.

C Q Wang1, K B Udupa, D A Lipschitz.   

Abstract

Interleukin-10 (IL-10) has been shown to exert anti-inflammatory effects by suppressing macrophage proliferation and inhibiting cytokine production. In this study we show that in the presence of erythropoietin (EPO), the addition of IL-10 results in a significant dose-dependent increase in both Burst Forming Unit-Erythroid (BFU-E) and Colony Forming Unit-Erythroid (CFU-E) colony growth in both serum-containing and serum-free murine cultures in vitro. IL-10 acts at the later stages of erythroid cell proliferation and differentiation as the increase in colony number was greater in CFU-E than in BFU-E, and was similar when IL-10 was added to BFU-E cultures at the time of culture initiation as when its addition to culture was delayed for 7 days. Furthermore, no increase in BFU-E colony number was noted when IL-10, added at the time of culture initiation, was neutralized by the addition to culture of a monoclonal anti-IL-10 antibody up to 7 days later. The increases in BFU-E by IL-10 addition were not the result of prolongation of BFU-E colony lifespan, which was not significantly different in IL-10 treated and control cultures, respectively. Rather IL-10 stimulated the proliferation of erythroid clusters that were now large enough to be recognized as colonies. IL-10-induced stimulation of erythropoiesis appeared to be independent of its inhibitory effects on macrophage function, as stimulation of erythroid colony growth was similar in macrophage-containing and depleted cultures. Studies to determine if the IL-10 effect was direct or indirect yielded equivocal results. A limiting dilution assay suggested a direct effect. However, a log/log dose response curve with IL-10 did not pass through the origin suggesting an indirect effect. These studies indicate that IL-10 acts synergistically with EPO to significantly increase stimulation of erythroid differentiation and proliferation in vitro and may be involved in the regulation of normal erythropoiesis in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8591990     DOI: 10.1002/(SICI)1097-4652(199602)166:2<305::AID-JCP8>3.0.CO;2-T

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

1.  Anemia and interleukin-10, tumor necrosis factor alpha, and erythropoietin levels among children with acute, uncomplicated Plasmodium falciparum malaria.

Authors:  V Nussenblatt; G Mukasa; A Metzger; G Ndeezi; E Garrett; R D Semba
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

2.  Intestinal inflammation modulates expression of the iron-regulating hormone hepcidin depending on erythropoietic activity and the commensal microbiota.

Authors:  Nanda Kumar N Shanmugam; Estela Trebicka; Ling-Lin Fu; Hai Ning Shi; Bobby J Cherayil
Journal:  J Immunol       Date:  2014-06-27       Impact factor: 5.422

Review 3.  African Trypanosomiasis-Associated Anemia: The Contribution of the Interplay between Parasites and the Mononuclear Phagocyte System.

Authors:  Benoit Stijlemans; Patrick De Baetselier; Stefan Magez; Jo A Van Ginderachter; Carl De Trez
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

4.  Association between inflammatory cytokine levels and anemia during Plasmodium falciparum and Plasmodium vivax infections in Mangaluru: A Southwestern Coastal Region of India.

Authors:  Kishore Punnath; Kiran K Dayanand; Valleesha N Chandrashekhar; Rajeshwara N Achur; Srinivasa B Kakkilaya; Susanta K Ghosh; Suchetha N Kumari; D Channe Gowda
Journal:  Trop Parasitol       Date:  2019-09-18

Review 5.  Adrenergic Modulation of Erythropoiesis After Trauma.

Authors:  Jennifer A Munley; Lauren S Kelly; Alicia M Mohr
Journal:  Front Physiol       Date:  2022-03-18       Impact factor: 4.755

6.  A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes.

Authors:  Edda María Elvarsdóttir; Teresa Mortera-Blanco; Marios Dimitriou; Thibault Bouderlique; Monika Jansson; Isabel Juliana F Hofman; Simona Conte; Mohsen Karimi; Birgitta Sander; Iyadh Douagi; Petter S Woll; Eva Hellström-Lindberg
Journal:  Leukemia       Date:  2019-08-02       Impact factor: 11.528

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.